Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver–kidney transplant recipients

Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver–kidney transplant recipients

Background De novo Donor Specific Antibodies (DSA) are considered as a risk factor for the kidney allograft outcomes in recipients after simultaneous liver–kidney transplantation (SLKT). We hypothesized that length of hospital stay (LOS) might be associated with de novo DSA development of due to the...

Full description

Bibliographic Details
Main Authors: Masahiko Yazawa, Orsolya Cseprekal, Ryan A. Helmick, Manish Talwar, Vasanthi Balaraman, Pradeep S. B. Podila, Sallyanne Fossey, Sanjaya K. Satapathy, James D. Eason, Miklos Z. Molnar
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Renal Failure
Subjects:
donor specific antibody
dsa
de novo dsa
simultaneous liver–kidney transplantation
length of hospital stay
hospitalization
Online Access:http://dx.doi.org/10.1080/0886022X.2019.1705338

Internet

http://dx.doi.org/10.1080/0886022X.2019.1705338

Similar Items